Literature DB >> 2926164

Azidothymidine steady-state pharmacokinetics in patients with AIDS and AIDS-related complex.

O L Laskin1, P de Miranda, M R Blum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926164     DOI: 10.1093/infdis/159.4.745

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  14 in total

Review 1.  Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.

Authors:  E J Arts; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 2.  Zidovudine (Retrovir) update.

Authors:  A R Rachlis
Journal:  CMAJ       Date:  1990-12-01       Impact factor: 8.262

3.  Fluorescence polarization immunoassay for zidovudine.

Authors:  G G Granich; M R Eveland; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.

Authors:  E Cañas; J Pachon; F Garcia-Pesquera; J R Castillo; P Viciana; J M Cisneros; M E Jimenez-Mejias
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 5.  Zidovudine toxicity. Clinical features and management.

Authors:  A Rachlis; M M Fanning
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

6.  Pharmacokinetic interaction between rifampin and zidovudine.

Authors:  D M Burger; P L Meenhorst; C H Koks; J H Beijnen
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

7.  Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients.

Authors:  K Gallicano; J Sahai; E Ormsby; D W Cameron; A Pakuts; I McGilveray
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

8.  Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys.

Authors:  S Kaul; K A Dandekar
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

9.  Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.

Authors:  B N Stretcher; A J Pesce; P T Frame; D S Stein
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

10.  Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics.

Authors:  Punna Rao Ravi; Udaya Kanth Kotreka; Ranendra Narayan Saha
Journal:  AAPS PharmSciTech       Date:  2008-01-25       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.